Fziomed’s Oxiplex gel earned the FDA’s de novo classification and marketing authorization for lumbar spine surgery, according to a July 8 news release. Oxiplex is the first intraoperative gel of its ...

Fziomed, Inc. ("Fziomed" or the "Company"), a recognized global leader in postsurgical adhesion prevention, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo ...

Sharad Rajpal, MD, performed the first U.S. case using Cerapedics’ PearlMatrix P-15 bone graft for lumbar spinal fusion since its FDA approval. The bone graft, the first of its kind for lumbar spinal ...

Lower back pain is the most common diagnosis seen by physical therapists. Most cases will resolve in less than two weeks with ...